Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Clinical trial NCT05900206 · RECRUITING
Trial details
- NCT number
- NCT05900206
- Sponsor
- Karolinska University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-26
- Primary completion
- 2027-04-30
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.